Pfizer Inc's Lipitor and AstraZeneca's Crestor cholesterol drugs, taken at their highest dose, safely reduced artery-clogging plaque in heart patients, according to data from a clinical trial ...

AstraZeneca outspent rivals Pfizer and Merck by 30% on consumer advertising for Crestor, helping the drug become the fastest-growing cholesterol treatment, Bloomberg.com reported.AstraZeneca spent ...

Although past peak sales, Lipitor, the gold standard therapy and highest selling brand commanded 40% of antidyslipidemic revenues in 2009. This will change dramatically after the loss of its patent ...

JUPITER Trial Results, Advantages in Efficacy and Fall Out from Vytorin and Zetia are Likely Drivers of Increased Patient Share for Crestor, According to a New Report from Decision Resources ...

In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well. Lipitor (atorvastatin) and Crestor (rosuvastatin) both effectively ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) today announced results of the LUNAR (Limiting UNdertreatment of Lipids in Acute Coronary Syndrome with Rosuvastatin) study, which showed ...

LONDON, Jan 15 (Reuters) - AstraZeneca Plc announced on Tuesday the first head-to-head clinical trial comparing its cholesterol-fighting drug Crestor with Pfizer Inc's Lipitor, the world's top-selling ...

Is Crestor dangerous? There have been rumors to that effect for years. Last month, the US Food and Drug Administration said no, arguing that there was no scientific evidence to implicate the drug. A ...

London, United Kingdom, Monday 6 September 2004. New data from the first international prospective study of statin treatment in people with the metabolic syndrome demonstrate that CRESTOR TM ...

ORLANDO, Fla., Nov 15 (Reuters) - Pfizer Inc's <PFE.N> Lipitor and AstraZeneca's <AZN.L> Crestor cholesterol drugs, taken at their highest dose, safely reduced artery-clogging plaque in heart patients ...